Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Journal Article

    Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • APR-246 increases tumor antigenicity independent of p53
    Journal Article

    Michels, J.; Venkatesh, D.; Liu, C.; Budhu, S.; Zhong, H.; George, M. M.; Thach, D.; Yao, Z. K.; Ouerfelli, O.; Liu, H.; more...
    Life Science Alliance (2024)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Vergote, I.; Mirza, M. R.; Coleman, R.; Fidalgo, J. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; Van Gorp, T.; Moore, K.; Sehouli, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • First-in-human phase 1/2 study of ubamatamab, a MUC16XCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer
    Meeting Abstract

    Moore, K.; Bouberhan, S.; Hamilton, E.; Liu, J. Y.; O'Cearbhaill, R.; O'Malley, D.; Papadimitriou, K.; Schröder, D.; Van Nieuwenhuysen, E.; Yoo, S. Y.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Priebe, A.; Duska, L.; Green, A.; Mathews, C.; Musa, F.; O'Malley, D.; Puechl, A.; Ding, L.; Schmid, A.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy
    Meeting Abstract

    Ocearbhaill, R.; Holmes, J.; Bastos, B.; Fu, S. Q.; Muenzen, R.; Cohen, J.; Cicic, D.; Ali, S.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes associated with postoperative chemotherapy following pelvic exenteration for recurrent or persistent gynecologic malignancies
    Meeting Abstract

    Zammarrelli, B.; Saini, A.; Rios-Doria, E.; Yeoshoua, E.; Jewell, E.; Tew, W.; Abu-Rustum, N.; Leitao, M.; Sonoda, Y.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Radiation quality and workflow in NRG GY017: Anti PD-L1 (atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer
    Meeting Abstract

    Mayadev, J.; Deng, W.; Zamarin, D.; Lankes, H.; Kim, H.; Chino, J.; Banberry, B.; Sherry, N.; Ghamande, S.; Ferguson, C.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Molecular characterization of stage I, grade 3 endometrioid endometrial cancer
    Meeting Abstract

    Zammarrelli, B.; Paula, A. D.; Manning-Geist, B.; Kim, S.; Leitao, M.; Abu-Rustum, N.; Makker, V.; Ellenson, L.; Mueller, J.; Weigelt, B.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Genomic evolution of uterine leiomyosarcoma: A study of serial recurrences
    Meeting Abstract

    Sia, T.; Miller, K.; Brown, D.; Selenica, P.; Paula, A. D.; Abu-Rustum, N.; Leitao, M.; Chiang, S.; Weigelt, B.; Hensley, M.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save